US Stock MarketDetailed Quotes

Bolt Biotherapeutics (BOLT)

Watchlist
  • 6.260
  • +0.010+0.16%
Trading Jan 23 10:32 ET
12.02MMarket Cap-0.28P/E (TTM)

Bolt Biotherapeutics (BOLT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
30.32%-9.73M
40.55%-9.6M
20.21%-13.37M
11.85%-61.29M
-1.16%-14.43M
16.62%-13.97M
-6.82%-16.14M
28.41%-16.75M
9.12%-69.53M
20.54%-14.27M
Net income from continuing operations
52.93%-7.14M
59.61%-8.56M
-2.12%-11.04M
8.79%-63.12M
10.99%-15.94M
6.65%-15.18M
-17.38%-21.2M
36.33%-10.81M
21.45%-69.2M
10.47%-17.9M
Operating gains losses
--0
--0
---288K
---70K
--0
----
----
----
----
----
Depreciation and amortization
-34.09%290K
-24.07%347K
-12.88%399K
-3.94%1.78M
-8.78%426K
-4.76%440K
-0.22%457K
-1.93%458K
11.28%1.85M
1.08%467K
Other non cash items
-20.80%636K
-20.81%624K
-20.44%615K
-22.19%2.3M
-108.84%-67K
7.93%803K
7.80%788K
7.51%773K
-8.47%2.95M
7.52%758K
Change In working capital
-555.88%-3.79M
-238.78%-2.46M
57.93%-3.55M
14.44%-8.44M
-177.71%-1.2M
78.53%-578K
242.47%1.77M
8.55%-8.44M
-222.67%-9.86M
298.84%1.54M
-Change in prepaid assets
-121.61%-86K
-103.01%-67K
-30.00%-169K
666.30%2.57M
-95.70%75K
131.34%398K
396.21%2.23M
90.56%-130K
49.72%-454K
1,017.89%1.74M
-Change in payables and accrued expense
-523.87%-1.88M
-191.80%-840K
29.15%-2.51M
-43.07%-4.88M
-327.10%-2.7M
-46.31%444K
-22.65%915K
46.39%-3.54M
-223.30%-3.41M
313.94%1.19M
-Change in other current liabilities
16.81%-594K
22.34%-525K
47.05%-368K
39.15%-1.46M
198.75%630K
-16.10%-714K
-16.55%-676K
-24.55%-695K
13.37%-2.39M
19.04%-638K
-Change in other working capital
-74.08%-1.23M
-48.63%-1.03M
87.64%-503K
-29.59%-4.67M
205.56%797K
56.79%-706K
-29.78%-693K
-496.05%-4.07M
-66.79%-3.61M
-809.64%-755K
Cash from discontinued investing activities
Operating cash flow
30.32%-9.73M
40.55%-9.6M
20.21%-13.37M
11.85%-61.29M
-1.16%-14.43M
16.62%-13.97M
-6.82%-16.14M
28.41%-16.75M
9.12%-69.53M
20.54%-14.27M
Investing cash flow
Cash flow from continuing investing activities
4.35%17.88M
-40.05%10.79M
42.61%14.55M
-18.95%57.58M
-22.63%12.23M
35.39%17.14M
32.57%18M
-64.81%10.2M
22.77%71.04M
-3.81%15.81M
Net PPE purchase and sale
-167.29%-72K
--0
--963K
151.94%107K
--0
164.85%107K
--0
--0
89.45%-206K
96.74%-6K
Net investment purchase and sale
5.43%17.96M
-40.05%10.79M
33.18%13.59M
-19.33%57.47M
-22.66%12.23M
32.82%17.03M
32.26%18M
-64.81%10.2M
19.11%71.24M
-4.84%15.82M
Cash from discontinued investing activities
Investing cash flow
4.35%17.88M
-40.05%10.79M
42.61%14.55M
-18.95%57.58M
-22.63%12.23M
35.39%17.14M
32.57%18M
-64.81%10.2M
22.77%71.04M
-3.81%15.81M
Financing cash flow
Cash flow from continuing financing activities
0
-57.31%108K
-72.64%29K
0
-49.70%253K
-26.39%106K
Net common stock issuance
--0
----
----
-57.31%108K
-72.64%29K
--0
----
----
-49.70%253K
-26.39%106K
Cash from discontinued financing activities
Financing cash flow
--0
-82.28%14K
--0
-57.31%108K
-72.64%29K
--0
--79K
--0
-49.70%253K
-26.39%106K
Net cash flow
Beginning cash position
42.66%11.37M
68.51%10.16M
-28.67%8.97M
16.34%12.58M
1.96%11.14M
-46.94%7.97M
-63.25%6.03M
16.34%12.58M
-62.66%10.81M
-10.32%10.93M
Current changes in cash
157.00%8.15M
-37.63%1.21M
118.11%1.19M
-304.13%-3.61M
-231.45%-2.17M
177.54%3.17M
240.07%1.94M
-217.10%-6.55M
109.74%1.77M
220.17%1.65M
End cash Position
75.22%19.52M
42.66%11.37M
68.51%10.16M
-28.67%8.97M
-28.67%8.97M
1.96%11.14M
-46.94%7.97M
-63.25%6.03M
16.34%12.58M
16.34%12.58M
Free cash flow
30.01%-9.8M
40.55%-9.6M
20.21%-13.37M
12.05%-61.33M
-1.11%-14.43M
17.19%-14.01M
-6.59%-16.14M
28.42%-16.75M
11.12%-69.73M
21.31%-14.27M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 30.32%-9.73M40.55%-9.6M20.21%-13.37M11.85%-61.29M-1.16%-14.43M16.62%-13.97M-6.82%-16.14M28.41%-16.75M9.12%-69.53M20.54%-14.27M
Net income from continuing operations 52.93%-7.14M59.61%-8.56M-2.12%-11.04M8.79%-63.12M10.99%-15.94M6.65%-15.18M-17.38%-21.2M36.33%-10.81M21.45%-69.2M10.47%-17.9M
Operating gains losses --0--0---288K---70K--0--------------------
Depreciation and amortization -34.09%290K-24.07%347K-12.88%399K-3.94%1.78M-8.78%426K-4.76%440K-0.22%457K-1.93%458K11.28%1.85M1.08%467K
Other non cash items -20.80%636K-20.81%624K-20.44%615K-22.19%2.3M-108.84%-67K7.93%803K7.80%788K7.51%773K-8.47%2.95M7.52%758K
Change In working capital -555.88%-3.79M-238.78%-2.46M57.93%-3.55M14.44%-8.44M-177.71%-1.2M78.53%-578K242.47%1.77M8.55%-8.44M-222.67%-9.86M298.84%1.54M
-Change in prepaid assets -121.61%-86K-103.01%-67K-30.00%-169K666.30%2.57M-95.70%75K131.34%398K396.21%2.23M90.56%-130K49.72%-454K1,017.89%1.74M
-Change in payables and accrued expense -523.87%-1.88M-191.80%-840K29.15%-2.51M-43.07%-4.88M-327.10%-2.7M-46.31%444K-22.65%915K46.39%-3.54M-223.30%-3.41M313.94%1.19M
-Change in other current liabilities 16.81%-594K22.34%-525K47.05%-368K39.15%-1.46M198.75%630K-16.10%-714K-16.55%-676K-24.55%-695K13.37%-2.39M19.04%-638K
-Change in other working capital -74.08%-1.23M-48.63%-1.03M87.64%-503K-29.59%-4.67M205.56%797K56.79%-706K-29.78%-693K-496.05%-4.07M-66.79%-3.61M-809.64%-755K
Cash from discontinued investing activities
Operating cash flow 30.32%-9.73M40.55%-9.6M20.21%-13.37M11.85%-61.29M-1.16%-14.43M16.62%-13.97M-6.82%-16.14M28.41%-16.75M9.12%-69.53M20.54%-14.27M
Investing cash flow
Cash flow from continuing investing activities 4.35%17.88M-40.05%10.79M42.61%14.55M-18.95%57.58M-22.63%12.23M35.39%17.14M32.57%18M-64.81%10.2M22.77%71.04M-3.81%15.81M
Net PPE purchase and sale -167.29%-72K--0--963K151.94%107K--0164.85%107K--0--089.45%-206K96.74%-6K
Net investment purchase and sale 5.43%17.96M-40.05%10.79M33.18%13.59M-19.33%57.47M-22.66%12.23M32.82%17.03M32.26%18M-64.81%10.2M19.11%71.24M-4.84%15.82M
Cash from discontinued investing activities
Investing cash flow 4.35%17.88M-40.05%10.79M42.61%14.55M-18.95%57.58M-22.63%12.23M35.39%17.14M32.57%18M-64.81%10.2M22.77%71.04M-3.81%15.81M
Financing cash flow
Cash flow from continuing financing activities 0-57.31%108K-72.64%29K0-49.70%253K-26.39%106K
Net common stock issuance --0---------57.31%108K-72.64%29K--0---------49.70%253K-26.39%106K
Cash from discontinued financing activities
Financing cash flow --0-82.28%14K--0-57.31%108K-72.64%29K--0--79K--0-49.70%253K-26.39%106K
Net cash flow
Beginning cash position 42.66%11.37M68.51%10.16M-28.67%8.97M16.34%12.58M1.96%11.14M-46.94%7.97M-63.25%6.03M16.34%12.58M-62.66%10.81M-10.32%10.93M
Current changes in cash 157.00%8.15M-37.63%1.21M118.11%1.19M-304.13%-3.61M-231.45%-2.17M177.54%3.17M240.07%1.94M-217.10%-6.55M109.74%1.77M220.17%1.65M
End cash Position 75.22%19.52M42.66%11.37M68.51%10.16M-28.67%8.97M-28.67%8.97M1.96%11.14M-46.94%7.97M-63.25%6.03M16.34%12.58M16.34%12.58M
Free cash flow 30.01%-9.8M40.55%-9.6M20.21%-13.37M12.05%-61.33M-1.11%-14.43M17.19%-14.01M-6.59%-16.14M28.42%-16.75M11.12%-69.73M21.31%-14.27M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More